1. Systemic antibiotic treatment in upper and lower respiratory tract infections: official French guidelines 
Agence Française de Sécurité, Sanitaire des Produits de Santé 
Clinical Microbiology and Infection 
Volume 9, Issue 12, Pages (December 2003)
DOI: /j x
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Current approach to treating common cold. *Respiratory discomfort, fever persisting more than 3 days or occuring after this period, persistence of the other symptoms (cough, rhinorrhoea, nasal obstruction) after 10 days with no signs of improvement, irritability, nocturnal awakening, otalgia, otorrhoea, purulent conjunctivitis, palpebral oedema, gastrointestinal disorders (anorexia, vomiting, diarrhoea) and skin rash.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2 Practical approach to treating pharyngitis.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

4. Figure 3
Initial therapeutic strategy in community-acquired pneumonia (without risk factor and without serious symptoms).
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

5. Figure 4
Secondary therapeutic strategy in community-acquired pneumonia (without risk factor or serious symptoms). *amoxicillin macrolides; more rarely : either amoxicillin + macrolide, either : telithromycin or fluoroquinolone active against pneumococcus.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

6. Figure 5
Diagnostic and therapeutic elements of respiratory tract infections in children
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

7. Figure 6
Therapeutic regimen for community-acquired pneumonia in children without risk factors
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions